USMLE Step 2 Quiz
Practice Polypharmacy And Medication Safety in USMLE Step 2 with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.
Question 1 / 20
0 of 20 answered
An 84-year-old woman is brought to the emergency department for an episode of syncope. Her medical history is notable for depression, hypertension, and chronic low back pain. Her medications are citalopram 20 mg daily, hydrochlorothiazide 25 mg daily, and cyclobenzaprine 5 mg as needed. An ECG shows a prolonged QTc interval of 520 ms. Laboratory studies show a potassium of 3.3 mEq/L.
Which of the following is the most significant contributing factor to this patient's QTc prolongation?
This quiz focuses on Polypharmacy And Medication Safety, giving you a quick way to practice the rules, question types, and explanations that matter most for USMLE Step 2.
Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.
An 84-year-old woman is brought to the emergency department for an episode of syncope. Her medical history is notable for depression, hypertension, and chronic low back pain. Her medications are citalopram 20 mg daily, hydrochlorothiazide 25 mg daily, and cyclobenzaprine 5 mg as needed. An ECG shows a prolonged QTc interval of 520 ms. Laboratory studies show a potassium of 3.3 mEq/L.
Which of the following is the most significant contributing factor to this patient's QTc prolongation?
Explanation: Citalopram causes dose-dependent QTc prolongation, particularly at doses ≥20 mg daily in elderly patients. This risk is significantly exacerbated by electrolyte abnormalities, especially hypokalemia. Hydrochlorothiazide commonly causes hypokalemia through renal potassium wasting. The combination of a QT-prolonging medication (citalopram) with drug-induced hypokalemia creates a synergistic effect that significantly increases the risk of dangerous arrhythmias like Torsades de Pointes, which likely caused her syncope. While cyclobenzaprine has mild anticholinergic effects, it is not a significant cause of QT prolongation.
A 78-year-old man with coronary artery disease and benign prostatic hyperplasia is started on a new medication for angina. His regular medications include aspirin, atorvastatin, and tamsulosin. He presents to the emergency department with profound dizziness, lightheadedness, and a blood pressure of 70/40 mmHg. He reports taking his new angina medication one hour after taking a sildenafil tablet for erectile dysfunction.
The severe hypotension is due to a synergistic interaction between sildenafil and which of the following medications?
Explanation: The concurrent use of nitrates (e.g., isosorbide mononitrate, nitroglycerin) and phosphodiesterase-5 (PDE-5) inhibitors (e.g., sildenafil) is an absolute contraindication. Both drug classes cause vasodilation through the nitric oxide-cGMP pathway. Their combined use leads to a synergistic and profound drop in blood pressure, which can be life-threatening. Beta-blockers (metoprolol) and calcium channel blockers (amlodipine) can lower blood pressure but do not have this dramatic synergistic effect with sildenafil. Ranolazine does not have a significant hemodynamic effect.
An 83-year-old woman with advanced dementia is brought from her nursing home with a 24-hour history of acute confusion and agitation. She has a fever of 38.6°C (101.5°F) and a urinalysis suggestive of a urinary tract infection. She is started on an appropriate antibiotic. For her severe agitation, the physician prescribes a low-dose medication. A few hours later, she becomes more lethargic and her confusion seems to have worsened.
The paradoxical worsening of her delirium was most likely caused by the administration of which of the following medications?
Explanation: Benzodiazepines, such as lorazepam, are known to cause or worsen delirium in older adults, particularly those with underlying dementia. This is a paradoxical reaction where a medication intended to sedate instead causes increased confusion and agitation. While antipsychotics like haloperidol and risperidone are often used cautiously for severe agitation in delirium, benzodiazepines are generally contraindicated unless the delirium is due to alcohol or benzodiazepine withdrawal. Acetaminophen would treat her fever but not worsen her delirium.
An 80-year-old man is being discharged from the hospital after placement of a drug-eluting stent for an acute coronary syndrome. His discharge medications include aspirin, clopidogrel, atorvastatin, and metoprolol. He has a long history of GERD, for which he takes omeprazole 40 mg daily.
Which of the following is the most significant potential drug-drug interaction in this patient's regimen?
Explanation: Omeprazole is a potent inhibitor of the enzyme CYP2C19. Clopidogrel is a prodrug that requires activation by CYP2C19 to exert its antiplatelet effect. By inhibiting this enzyme, omeprazole can reduce the activation of clopidogrel, potentially leading to decreased antiplatelet activity and an increased risk of in-stent thrombosis. While the clinical significance is debated, guidelines often recommend using a PPI with less CYP2C19 inhibition, such as pantoprazole, or separating the administration times. The other potential interactions listed are of less clinical significance.
A 74-year-old man with hypertension and chronic constipation is prescribed a new medication. A week later, he presents with acute urinary retention requiring catheterization. His regular medications are amlodipine and polyethylene glycol. His prostate is mildly enlarged on examination.
The new medication was most likely prescribed for which of the following conditions?
Explanation: The patient developed acute urinary retention, which is a classic anticholinergic adverse effect, particularly problematic in men with underlying benign prostatic hyperplasia. Medications commonly used for neuropathic pain include tricyclic antidepressants (such as amitriptyline or nortriptyline), which have potent anticholinergic properties that can cause urinary retention, dry mouth, constipation, and confusion. Modern antihistamines for allergies have minimal anticholinergic effects, and PDE-5 inhibitors for erectile dysfunction do not cause anticholinergic side effects.
An 86-year-old woman is evaluated for a recent decline in her mobility and an increase in daytime sleepiness. Her medical history includes chronic pain from spinal stenosis, depression, and hypertension. Her medication list includes extended-release morphine, duloxetine, and lisinopril. A month ago, gabapentin was initiated and titrated up for her pain.
The patient's worsening somnolence is most likely due to an interaction between which two medications?
Explanation: Both opioids (morphine) and gabapentinoids (gabapentin) are central nervous system depressants. When used concurrently, they have a synergistic effect that can lead to profound sedation, somnolence, and respiratory depression. This combination is particularly high-risk in older adults. While duloxetine can also cause drowsiness, the combination of an opioid and gabapentin is a well-known and dangerous interaction that is the most likely cause of her significant decline.
A 72-year-old woman with atrial fibrillation, osteoarthritis, and hypothyroidism is seen in clinic. Her medications include warfarin, levothyroxine, and acetaminophen as needed. Her INR has been stable for years. She recently started taking an over-the-counter herbal supplement for low mood. Her INR today is 1.2 (target 2.0-3.0).
The use of which of the following supplements is the most likely cause for her subtherapeutic INR?
Explanation: St. John's wort is a potent inducer of the cytochrome P450 system, particularly CYP3A4 and CYP2C9. Warfarin is metabolized by these enzymes. By inducing the enzymes, St. John's wort accelerates the metabolism of warfarin, leading to lower drug levels and a subtherapeutic INR, which increases the risk of thromboembolic events. Ginkgo biloba can increase bleeding risk but does not typically lower the INR. Saw palmetto and glucosamine do not have a well-established, clinically significant interaction with warfarin.
A 75-year-old woman with diabetes, hypertension, and peripheral neuropathy presents with a new, persistent dry cough that began a month ago. She also feels lightheaded when she stands. Her medications include metformin, lisinopril, and amitriptyline. Her physician considers her symptoms to be medication side effects.
Which of the following interventions exemplifies the avoidance of a 'prescribing cascade'?
Explanation: A prescribing cascade occurs when a new medication is added to treat the side effect of another medication, rather than addressing the root cause. The patient's cough is a classic side effect of lisinopril (an ACE inhibitor). Adding a cough suppressant like dextromethorphan would be a prescribing cascade. The most appropriate action to avoid this is to identify the offending agent and stop it. Discontinuing lisinopril and likely substituting it with an angiotensin receptor blocker (ARB) directly addresses the cause of the side effect.
An 82-year-old man with type 2 diabetes and hypertension reports several episodes of shakiness, sweating, and confusion in the mornings before lunch. A fingerstick glucose in the clinic is 52 mg/dL. His medications are metformin 1000 mg twice daily and glyburide 10 mg daily. His most recent HbA1c was 6.7%. His eGFR is 55 mL/min/1.73m².
Which of the following is the most appropriate next step in managing his diabetes?
Explanation: Glyburide is a long-acting sulfonylurea that is on the Beers Criteria list of medications to be avoided in older adults. It carries a high risk of severe and prolonged hypoglycemia due to its long duration of action and active metabolites that are cleared by the kidneys. Given the patient's symptomatic hypoglycemia, the safest and most appropriate action is to discontinue this high-risk medication entirely and consider a safer alternative (e.g., a DPP-4 inhibitor, GLP-1 agonist, or even a shorter-acting sulfonylurea like glipizide if necessary). Simply reducing the dose or adding a snack does not adequately address the inherent risk of the drug.
A 79-year-old man with chronic kidney disease (eGFR 25 mL/min/1.73m²), hypertension, and gout presents with an acutely swollen, red, and painful first metatarsophalangeal joint. His medications include amlodipine and lisinopril.
Which of the following is the most appropriate initial treatment for his acute gout flare?
Explanation: In a patient with significant chronic kidney disease, NSAIDs like indomethacin are contraindicated as they can cause acute kidney injury. Colchicine is cleared by the kidneys, and its use in severe CKD carries a high risk of toxicity (e.g., myelosuppression, neuropathy); if used, it requires significant dose reduction. Allopurinol is a urate-lowering therapy used for long-term prevention and is not indicated for treating an acute flare. Therefore, corticosteroids (oral prednisone or an intra-articular injection) are the safest and most effective first-line treatment for an acute gout flare in this patient.
An 88-year-old cognitively intact woman lives independently. Her medications include long-acting nifedipine, metformin, alprazolam 0.5 mg three times daily for anxiety, and zolpidem 10 mg nightly. She complains of morning confusion and near falls when getting to the bathroom at night. Vital signs are normal, and labs are unremarkable. Which intervention is the best initial step?
Explanation: When evaluating elderly patients with confusion and falls, you must systematically assess medications for potentially harmful effects. This patient's symptoms of morning confusion and nighttime near-falls strongly suggest medication-related cognitive impairment and sedation. The correct answer is A because alprazolam is a benzodiazepine with significant risks in elderly patients. Benzodiazepines cause prolonged sedation, cognitive impairment, and increased fall risk due to their long half-lives and altered metabolism in older adults. The Beers Criteria specifically recommend avoiding benzodiazepines in patients ≥65 years due to these dangers. Her symptoms directly correlate with alprazolam's effects, making gradual discontinuation the most appropriate intervention. Option B is incorrect because while zolpidem (a Z-drug) can contribute to falls, trazodone also carries sedation risks and doesn't address the primary culprit. Additionally, switching sleep medications doesn't eliminate the benzodiazepine problem. Option C misses the mark because her vital signs are normal, suggesting orthostatic hypotension isn't the issue. Nifedipine actually causes less orthostatic hypotension than many antihypertensives. Option D is inappropriate because she's cognitively intact during the day - this isn't dementia requiring memantine. Her confusion is medication-induced, not due to underlying cognitive decline. Study tip: In elderly patients with new confusion or falls, always suspect medications first, especially benzodiazepines, anticholinergics, and sedatives. The Beers Criteria are high-yield for Step 2 - know that benzodiazepines should be avoided in elderly patients due to fall and cognitive risks.
A 79-year-old man with chronic low back pain receives meperidine 50 mg orally every 6 hours as needed after a recent hospital admission. One week later he becomes agitated and disoriented at home. Temperature is 38.3 °C, but workup for infection is negative. Which step will most likely resolve his symptoms?
Explanation: When you encounter an elderly patient on meperidine who develops agitation and disorientation, think meperidine toxicity. Meperidine has a unique and dangerous metabolite called normeperidine that accumulates in elderly patients and those with renal impairment, causing CNS toxicity including delirium, agitation, and even seizures. The correct approach is A) Stop meperidine and convert to low-dose oral morphine. Meperidine should be discontinued immediately when CNS toxicity is suspected. Morphine is a safer opioid alternative that doesn't produce toxic metabolites like normeperidine. The patient still needs pain control, so switching rather than just stopping is appropriate. B) Adding haloperidol treats the symptoms but ignores the underlying cause. The agitation will persist as long as meperidine continues and normeperidine keeps accumulating. C) Broad-spectrum antibiotics might seem logical given the fever, but the negative infection workup combined with recent meperidine use makes drug toxicity far more likely. Normeperidine can cause hyperthermia as part of its toxicity syndrome. D) Lorazepam for alcohol withdrawal has no supporting evidence in this case. There's no mention of alcohol use history, and the timeline coincides with meperidine initiation, not alcohol cessation. Key takeaway: Meperidine is contraindicated in elderly patients due to normeperidine accumulation. On Step 2, always suspect meperidine toxicity when you see an older patient developing new neurologic symptoms after starting this medication. Other opioids like morphine or oxycodone are much safer choices.
An 80-year-old woman is brought to clinic by her daughter because of two falls over the past month. She reports lightheadedness on standing but no chest pain or palpitations. BP is 122/70 mm Hg supine and 98/60 mm Hg standing; pulse is 70/min supine and 68/min standing. She ambulates slowly but without focal neurologic deficits. Current medications are lisinopril, hydrochlorothiazide, metformin, naproxen as needed, amitriptyline 25 mg nightly for neuropathic pain, and calcium/vitamin D. Which medication is the most appropriate target for deprescribing to reduce her fall risk?
Explanation: When evaluating falls in elderly patients, always consider medication-related orthostatic hypotension as a key modifiable risk factor. This patient's vital signs show classic orthostatic hypotension (drop >20 mmHg systolic) with minimal heart rate response, suggesting medication effect rather than volume depletion. Amitriptyline (A) is the best target for deprescribing because tricyclic antidepressants are potent alpha-1 adrenergic blockers that cause significant orthostatic hypotension. They're also anticholinergic, causing sedation and cognitive impairment that further increase fall risk. For neuropathic pain in elderly patients, safer alternatives include gabapentin or topical agents. The 25 mg dose, while seemingly low, is still problematic in an 80-year-old due to age-related pharmacokinetic changes. Hydrochlorothiazide (B) can contribute to orthostatic hypotension through volume depletion, but it's likely needed for her hypertension management. The standing BP of 98/60 suggests her hypertension isn't well-controlled off antihypertensives. Metformin (C) doesn't cause orthostatic hypotension and is generally well-tolerated in elderly patients with normal kidney function. Naproxen (D) increases fall risk through different mechanisms (GI bleeding, cardiovascular events) but doesn't directly cause the orthostatic hypotension pattern seen here. Study tip: For USMLE Step 2, remember the "anticholinergic burden" concept—tricyclics, antihistamines, and antipsychotics are high-yield culprits for falls in elderly patients. Always look for medications that can be safely discontinued rather than adding new treatments.
A 76-year-old man with chronic atrial fibrillation takes warfarin for stroke prevention. His INR has been stable between 2.0 and 3.0. He now develops acute prostatitis, and trimethoprim-sulfamethoxazole is recommended by the urgent-care physician. You are contacted to review the plan. What is the most appropriate next step to minimize medication-related harm?
Explanation: When managing patients on warfarin who need additional medications, you must always consider drug interactions that can significantly alter anticoagulation. Warfarin has a narrow therapeutic window, and interactions can lead to dangerous bleeding or thrombotic complications. Trimethoprim-sulfamethoxazole (TMP-SMX) is a potent inhibitor of CYP2C9, the primary enzyme responsible for warfarin metabolism. This interaction can increase warfarin levels by 25-50%, dramatically raising bleeding risk even with unchanged dosing. The safest approach is avoiding this combination entirely when equally effective alternatives exist. Option A is correct because ciprofloxacin is an excellent alternative for treating acute prostatitis with good prostatic penetration and minimal warfarin interaction. This eliminates the drug interaction risk while maintaining therapeutic efficacy. Option B is problematic because even with monitoring, the TMP-SMX interaction begins immediately and can cause dangerous INR elevations before the 5-7 day recheck. Reactive monitoring doesn't prevent initial harm. Option C attempts to preemptively adjust warfarin dosing, but the degree of interaction varies significantly between patients, making predetermined dose reductions unreliable and potentially still dangerous. Option D creates unnecessary thrombotic risk by completely stopping anticoagulation. A 76-year-old with chronic atrial fibrillation has substantial stroke risk that shouldn't be eliminated for a drug interaction that can be avoided through better antibiotic selection. Study tip: Always consider whether drug interactions can be avoided through alternative medications before attempting to manage them through dose adjustments or increased monitoring. Prevention beats reaction in anticoagulation management.
A 79-year-old man has chronic allergic rhinitis. Over-the-counter diphenhydramine 25 mg nightly helps him sleep and relieves congestion. He also takes metoprolol, insulin glargine, and tamsulosin. He recently developed urinary retention requiring catheterization. Which substitution is most appropriate to address the likely medication-induced cause?
Explanation: When evaluating urinary retention in elderly patients on multiple medications, you need to identify drugs with anticholinergic effects that can impair bladder contractility. Diphenhydramine, a first-generation antihistamine, has significant anticholinergic properties that commonly cause urinary retention, especially in older adults. The correct approach is A - replacing diphenhydramine with intranasal saline plus a second-generation antihistamine like loratadine. Second-generation antihistamines have minimal anticholinergic effects because they don't readily cross the blood-brain barrier, making them much safer for elderly patients while still providing allergy relief. B is incorrect because adding oxybutynin would worsen the problem - it's an anticholinergic medication that would further impair bladder emptying rather than help it. This represents a dangerous approach that could exacerbate urinary retention. C is wrong because tamsulosin actually helps bladder emptying by relaxing the prostate and bladder neck. Switching to finasteride (which shrinks the prostate but takes months to work) would remove a beneficial medication and likely worsen urinary symptoms. D is incorrect because metoprolol doesn't significantly affect bladder function. While beta-blockers can theoretically reduce detrusor contractility, this is not a clinically significant cause of urinary retention compared to anticholinergic effects. Key takeaway: Always suspect anticholinergic medications (especially first-generation antihistamines like diphenhydramine) when elderly patients develop urinary retention. The "anticholinergic burden" is a major cause of adverse effects in geriatric patients.
A 77-year-old woman with systolic heart failure takes furosemide, carvedilol, lisinopril, spironolactone 25 mg daily, and digoxin 0.125 mg daily (digoxin level 0.8 ng/mL 2 months ago). She develops new-onset atrial flutter, and the cardiologist starts amiodarone 400 mg orally twice daily. Two weeks later she reports nausea and blurred vision. Vitals are stable. Which medication adjustment is most appropriate?
Explanation: Drug interactions are a critical concern in polypharmacy, especially when adding new medications to established regimens. This question tests your understanding of the significant interaction between amiodarone and digoxin. Amiodarone is a potent P-glycoprotein inhibitor that dramatically reduces digoxin clearance, leading to a 70-100% increase in serum digoxin levels within 1-2 weeks. The patient's symptoms of nausea and blurred vision are classic signs of digoxin toxicity. Even though her previous digoxin level was therapeutic at 0.8 ng/mL, the addition of amiodarone has likely pushed her into the toxic range (>2.0 ng/mL). The timing—symptoms appearing two weeks after starting amiodarone—perfectly matches this interaction's onset. Choice A is correct because digoxin doses should be reduced by 50% when starting amiodarone to prevent toxicity. This is a well-established, evidence-based recommendation. Choice B is incorrect because increasing furosemide would worsen the situation by potentially causing hypokalemia, which increases digoxin sensitivity and toxicity risk. Furosemide doesn't significantly enhance digoxin excretion. Choice C is wrong because spironolactone helps maintain potassium levels, protecting against digoxin toxicity. Discontinuing it could lead to hypokalemia. Amiodarone doesn't cause clinically significant hyperkalemia. Choice D ignores clear signs of drug interaction. The temporal relationship and classic symptoms make medication-related toxicity the most likely cause. Study tip: Memorize this high-yield interaction: amiodarone + digoxin = reduce digoxin dose by 50%. Watch for digoxin toxicity symptoms (nausea, vision changes, arrhythmias) whenever new medications are added.
An 82-year-old woman with osteoarthritis takes acetaminophen 1 g four times daily but still has knee pain. Her primary physician adds ibuprofen 600 mg three times daily. Three weeks later she presents with generalized weakness and serum creatinine 2.1 mg/dL (baseline 1.3 mg/dL) and potassium 5.8 mEq/L. Other medications include lisinopril and hydrochlorothiazide. Which mechanism best explains her acute kidney injury?
Explanation: When you encounter acute kidney injury in elderly patients on multiple medications, always consider the "triple whammy" combination: NSAIDs, ACE inhibitors, and diuretics. This scenario perfectly illustrates how these drugs work synergistically to impair renal function. Normally, kidneys maintain glomerular filtration through autoregulation - when blood flow decreases, prostaglandins cause afferent arteriole dilation while angiotensin II causes efferent arteriole constriction, preserving filtration pressure. The ibuprofen blocks prostaglandin synthesis (reducing afferent dilation), lisinopril blocks angiotensin II (reducing efferent constriction), and hydrochlorothiazide causes volume depletion. Together, they eliminate the kidney's ability to maintain adequate filtration pressure, resulting in prerenal azotemia. The hyperkalemia occurs because reduced GFR impairs potassium excretion, and ACE inhibitors further limit aldosterone-mediated potassium elimination. Choice A correctly identifies this triple drug interaction causing prerenal azotemia. Choice B is incorrect because hyperkalemia doesn't cause rhabdomyolysis - it's typically a consequence, not a cause, of muscle breakdown. Choice C describes NSAID-induced interstitial nephritis, which usually presents with fever, rash, and eosinophilia after weeks of use, not the acute presentation seen here. Choice D is wrong because acetaminophen nephrotoxicity requires massive overdoses (>10g) and causes acute tubular necrosis, not the prerenal pattern demonstrated. Remember: When you see elderly patients on ACE inhibitors and diuretics developing AKI after starting NSAIDs, think "triple whammy" - it's a high-yield USMLE concept and common clinical scenario.
A 75-year-old man with depression controlled on sertraline 100 mg daily is diagnosed with diabetic foot osteomyelitis. The infectious-disease consultant recommends linezolid for 6 weeks because of resistant gram-positive organisms. Which action is most appropriate to avoid a serious drug interaction?
Explanation: When you encounter questions about drug interactions involving psychiatric medications, always consider serotonin syndrome as a potentially life-threatening emergency that requires immediate intervention. Linezolid is an antibiotic that acts as a weak, reversible monoamine oxidase inhibitor (MAOI). When combined with serotonergic medications like sertraline (an SSRI), this creates a high risk for serotonin syndrome - a potentially fatal condition characterized by altered mental status, autonomic instability, and neuromuscular abnormalities. The interaction between linezolid and SSRIs is well-documented and clinically significant. The correct answer is A because sertraline must be discontinued before starting linezolid. Given sertraline's half-life, you should wait at least 5 half-lives (about 5-7 days) after discontinuation before starting linezolid to ensure adequate clearance and minimize interaction risk. Answer B is incorrect because simply reducing the sertraline dose doesn't eliminate the interaction risk - even lower doses can precipitate serotonin syndrome when combined with an MAOI. Answer C is wrong because cyproheptadine is used to treat serotonin syndrome after it occurs, not prevent it, and using it prophylactically while continuing the offending agents is inappropriate. Answer D is dangerous because serotonin syndrome from this specific combination is actually well-documented and potentially fatal, not rare. Remember: linezolid + any serotonergic agent = high serotonin syndrome risk. Always discontinue SSRIs/SNRIs before starting linezolid, and don't restart them until linezolid is completed and cleared.
An 84-year-old woman with hypertension, stage 4 chronic kidney disease (eGFR 22 mL/min/1.73 m²), and symptomatic nonvalvular atrial fibrillation is hospitalized for community-acquired pneumonia. Home medications include lisinopril, furosemide, simvastatin, and apixaban 5 mg twice daily started 4 months ago. Her serum creatinine has risen from 2.0 to 2.6 mg/dL since then. What is the most appropriate medication change to reduce adverse drug events?
Explanation: When managing anticoagulation in patients with severe chronic kidney disease, you must understand that apixaban has specific contraindications based on renal function. Unlike warfarin, which is primarily metabolized hepatically, direct oral anticoagulants (DOACs) like apixaban have varying degrees of renal elimination. Apixaban is contraindicated when creatinine clearance falls below 25 mL/min or when creatinine rises to ≥2.5 mg/dL in patients on treatment. This patient's creatinine has increased from 2.0 to 2.6 mg/dL with an eGFR of 22 mL/min, placing her beyond the safe threshold for apixaban use. The appropriate management is to discontinue apixaban and transition to warfarin, which remains the preferred anticoagulant in severe CKD. Bridging with low-molecular-weight heparin prevents thrombotic events during the transition period before warfarin reaches therapeutic levels. Choice A is incorrect because dose reduction alone is insufficient when creatinine exceeds 2.5 mg/dL—apixaban should be discontinued entirely at this level of renal impairment. Choice C ignores the clear contraindication and puts the patient at risk for bleeding complications. Choice D is problematic because holding anticoagulation in symptomatic atrial fibrillation significantly increases stroke risk, and her baseline kidney function may not return given her stage 4 CKD. Remember this threshold: apixaban becomes contraindicated when creatinine rises above 2.5 mg/dL or eGFR drops below 25 mL/min. At that point, transition to warfarin with appropriate bridging—don't just reduce the DOAC dose.
An 85-year-old woman with osteoporosis, gastroesophageal reflux disease, and chronic kidney disease stage 3 takes alendronate weekly, omeprazole, calcium carbonate, vitamin D, and ferrous sulfate for iron-deficiency anemia. She complains that she can never fit all her pills around mealtime instructions. Which intervention will streamline her regimen without sacrificing efficacy?
Explanation: When you encounter medication management questions, focus on drug-specific absorption requirements and potential interactions that affect efficacy. The key issue here is that calcium carbonate requires gastric acid for optimal absorption, but this patient takes omeprazole (a proton pump inhibitor) that significantly reduces stomach acid production. This creates a problematic interaction where the calcium isn't well absorbed, forcing complex timing around meals and medications. Switching to calcium citrate (option A) solves this elegantly because calcium citrate doesn't require gastric acid for absorption - it can be taken with or without food and isn't affected by acid-suppressing medications. This eliminates the need to time calcium around omeprazole doses, significantly simplifying her regimen while maintaining calcium efficacy. Option B is dangerous because both ferrous sulfate and alendronate can cause significant GI irritation, and taking them together increases this risk substantially. Additionally, iron can interfere with bisphosphonate absorption. Option C is incorrect because omeprazole doesn't meaningfully reduce bisphosphonate absorption - the issue is with calcium, not alendronate. Plus, discontinuing omeprazole could worsen her GERD. Option D is wrong because elderly patients typically have reduced skin synthesis of vitamin D and often have limited sun exposure, making supplementation necessary, especially with her osteoporosis. Remember for Step 2: When patients struggle with medication timing, look for formulation switches that eliminate pH-dependent absorption issues. Calcium citrate vs. carbonate is a high-yield distinction that frequently appears in geriatric medication management scenarios.